Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
1.19 Up 0.03(2.59%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - IMMUNOCELLULAR THERAPEUTICS LTD. (IMUC-A)10$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 16, 2014GlobalDataGlobalDataImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review47$125
Apr 11, 2014Reuters Investment ProfileN/AImmunoCellular Therapeutics Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ACOR , AFFY , BSTC , IMUC , TELK -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: IMMUNOCELLULAR -- IMUC1$11.50
Mar 12, 2014Thomson Reuters StreetEventsResearch DepartmentIMUC.A - Event Transcript of ImmunoCellular Therapeutics Ltd conference call, Mar. 13, 2014 / 5:00PM ET14$75

View All Reports for IMUC ...